MedTrace Logo

Clinical Outcomes With Bilateral Implantation of Odyssey IOLs

NCT06550375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-04-08

Study results available
· View outcomes & findings →

Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.

Conditions

  • Cataract

Interventions

DEVICE

TECNIS Odyssey IOL

Implantation with the TECNIS Odyssey IOL

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Mann Eye Institute

    lead OTHER

Principal Investigators

  • Phillip Brunson, OD · Mann Eye Institute

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-05
Primary Completion
2025-03-26
Completion
2025-03-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550375 on ClinicalTrials.gov